Breast Cancer: Big Questions Answered?Breast Cancer: Big Questions Answered?

Dr Kathy Miller previews the top ASCO 2016 breast cancer studies, which may provide definitive answers about anthracyclines in HER2-negative BC and optimal duration for adjuvant aromatase inhibitors. Medscape Oncology

Source: Medscape Hematology-Oncology Headlines - May 24, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news